Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

Protracted venous infusion 5-fluorouracil (5FU) combined with mitomycin C (MMC) has demonstrated significant activity against metastatic colorectal cancer. Owing to potential synergy based upon upregulation of thymidine phosphorylase by MMC, the combination of capecitabine and MMC may improve outcom...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chong, G, Dickson, J L B, Cunningham, D, Norman, A R, Rao, S, Hill, M E, Price, T J, Oates, J, Tebbutt, N
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2005
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361607/
https://ncbi.nlm.nih.gov/pubmed/16091760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602733
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky